Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Untreatable Eczema Beat with Arthritis Drug, Yale Researchers Say

July 22, 2015 8:29 am | by Seth Augenstein, Digital Reporter | News | Comments

An arthritis drug can beat chronic eczema, according to a new study by Yale researchers. Tofacitinib citrate, used for rheumatoid arthritis, led to dramatic improvement in eczema in six patients with moderate to severe forms of the chronic ailment, who had previously tried conventional treatments without improvement, according to the study. Read more...

TOPICS:

Aspirin’s Myriad Effects on Breast Cancer

July 22, 2015 8:20 am | by Cynthia Fox, Science Editor | Articles | Comments

A July Laboratory Investigation report found aspirin may render the environment of cancer stem cells, which can linger post-chemo, hostile to replication. Aspirin may also ward off breast cancer prophylactically, according to the study led by Sushanta Banerjee, Ph.D., research director of the Cancer Research Unit at the Kansas City (Mo.) Veterans Affairs Medical Center. Read more...

TOPICS:

Delcath Receives Orphan Drug Designation To Treat Cholangiocarcinoma

July 21, 2015 1:12 pm | News | Comments

Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announced today that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has granted Orphan Drug Designation for  melphalan  for the treatment of  cholangiocarcinoma. Read more...

TOPICS:
Advertisement

BMS Gains Breakthrough Therapy Designation for New HIV Treatment

July 21, 2015 1:10 pm | by Ryan Bushey, Associate Editor | News | Comments

The company believes this drug has a considerable edge over other therapies currently on the market. Read more...

TOPICS:

Universal Flu Vaccine in the Works

July 21, 2015 12:52 pm | by American Society for Microbiology | News | Comments

Each year, scientists create an influenza (flu) vaccine that protects against a few specific influenza strains that researchers predict are going to be the most common during that year. Read more...

TOPICS:

FDA Approves Abbott's iDesign System for Vision Treatment

July 21, 2015 12:27 pm | News | Comments

Abbott announced today the U.S. Food and Drug Administration approval and launch of the iDesign Advanced WaveScan Studio System. The system acts as the "brain" of the LASIK procedure, generating a high-definition scan that measures and maps irregularities of the eye that may impact vision. Read more...

TOPICS:

Team Links Gene Expression, Immune System with Cancer Survival Rates

July 21, 2015 12:12 pm | by Krista Conger, Stanford University | News | Comments

Linking gene expression patterns and immune system response to patient survival rates in nearly 18,000 cases of 39 types of cancers illuminates broad prognostic correlations. Read more...

TOPICS:

Studies: Better Sleep May Be Important for Alzheimer's Risk

July 21, 2015 12:01 pm | by Lauren Neergaard, AP Medical writer - Associated Press | News | Comments

To sleep, perchance to... ward off Alzheimer's? New research suggests poor sleep may increase people's risk of Alzheimer's disease, by spurring a brain-clogging gunk that in turn further interrupts shut-eye. Read more...

TOPICS:
Advertisement

Amgen Gains EU Approval for New Cholesterol Lowering Medication

July 21, 2015 8:37 am | News | Comments

The effect of Repatha on cardiovascular morbidity and mortality has not yet been determined. Read more...

TOPICS:

HerpV, GEN-003 Will Drive Genital Herpes Treatment Market Growth to 2023

July 21, 2015 8:32 am | by Daian Cheng, Ph.D., Infectious Disease Analyst, GlobalData | Articles | Comments

The low price of generic drugs not only will limit the sales of existing treatment, it also poses an entry barrier for new therapies. Read more...

TOPICS:

Tekmira Announces Corporate Shift to Focus on Hepatitis B Cures

July 21, 2015 8:20 am | News | Comments

The combined entity currently fields the largest portfolio of HBV product candidates in the industry and is led by an experienced and proven leadership team shown below with notable prior experience. Read more...

TOPICS:

Doctors Say Teen's HIV in Check for 12 Years without Drugs

July 21, 2015 8:19 am | by Marilynn Marchione, AP Medical Writer | News | Comments

An 18-year-old French teen born with the AIDS virus has had her infection under control and nearly undetectable despite stopping treatment 12 years ago - an unprecedented remission. Read more...

TOPICS:

Scientists Find New Variant of Streptococcal Bacteria Causing Severe Infections

July 21, 2015 8:18 am | by Imperial College London | News | Comments

Japan, Canada, France and Sweden have reported a surge in the same strain type, raising the possibility that the new variant is spreading globally. Read more...

TOPICS:

FDA Approves Novo Nordisk's Treatment for Growth Hormone Related Disorders

July 21, 2015 8:18 am | News | Comments

Norditropin FlexPro is the only prefilled growth hormone injection pen that can be stored outside of the refrigerator for up to 21 days after first use. Read more...

TOPICS:

Possibility of Predicting Alzheimer’s With Saliva Test

July 20, 2015 1:14 pm | by Stephanie Guzowski, Editor | News | Comments

Could a saliva test help determine if someone has Alzheimer’s disease? Although the research is very preliminary, scientists say they have pinpointed a series of chemical compounds in saliva that can differentiate between people with normal aging, those with mild cognitive impairment (MCI), and Alzheimer’s disease. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading